Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • ik76
    Junior Member
    • Jan 2010
    • 9

    problem with Illumina PE RNA seq alingment

    Hi All,
    We recently started to do PE RNA seq and we encountered a problem the cause of which have eluded us so far. In summary, following cycle 30 we see rapid increase in alignment error. The error rates per cycle go up to 20% and the % reads with 1 or more mismatches goes up to 35-50%.
    What we have found is:
    1) The error is alingner-nonspecific ( we tested eland, bowtie and even commercial software).


    2) The error is not due to contamination with amplified adapters or low quality scores for the bases in the second half of the amplicons.

    3) The problem is RNA-specific. Both PhiX and genomic DNA samples had normal error and alignment plots.

    4) The problem seems to depend on both the length of the insert and the length of the run. During the same run, shorter insert libraries have more misaligned reads than libraries consisting of longer fragments. A given insert size library will have more misaligned reads during a longer run.

    5) There is nothing visibly and strongly wrong with the IVC plots of the affected samples. The only striking observation is that both the % basecall as well as (even more strongly) the % all intensities from the affected samples form some type of ‘fork’ structures in the later cycles of each read.

    Has anybody heard about such a problem or encountered it? Any suggestions are welcomed.

    We know that the problem is related to the sample prep and taking longer reads ( >200bp insert size) will help alleviate it but we wonder what is the cause of it?

Latest Articles

Collapse

  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    07-08-2026, 05:17 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 07-20-2026, 11:10 AM
0 responses
14 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-13-2026, 10:26 AM
0 responses
31 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-09-2026, 10:04 AM
0 responses
42 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-08-2026, 10:08 AM
0 responses
28 views
0 reactions
Last Post SEQadmin2  
Working...